These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 20380620

  • 1. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
    Schennach-Wolff R, Jäger M, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, Gastpar M, Seemüller F, Möller HJ, Riedel M.
    World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
    [Abstract] [Full Text] [Related]

  • 2. Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia.
    de Haan L, Nimwegen Lv, Amelsvoort Tv, Dingemans P, Linszen D.
    Pharmacopsychiatry; 2008 Jul; 41(4):125-8. PubMed ID: 18651339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.
    Balestrieri M, Giaroli G, Mazzi M, Bellantuono C.
    Pharmacopsychiatry; 2006 May; 39(3):81-4. PubMed ID: 16721695
    [Abstract] [Full Text] [Related]

  • 5. [Subjective view of positive symptoms and quality of life in patients with schizophrenia].
    Karow A, Schäfer I, Hirdes F, Osterwald C, Naber D.
    Psychiatr Prax; 2008 Sep; 35(6):286-93. PubMed ID: 18504688
    [Abstract] [Full Text] [Related]

  • 6. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr 13; 31(3):703-12. PubMed ID: 17289237
    [Abstract] [Full Text] [Related]

  • 7. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B, Nemoto T, Fujii C, Mizuno M.
    Psychiatry Clin Neurosci; 2009 Aug 13; 63(4):521-8. PubMed ID: 19531107
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
    Schennach-Wolff R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M.
    J Psychiatr Res; 2011 Dec 13; 45(12):1639-47. PubMed ID: 21862035
    [Abstract] [Full Text] [Related]

  • 12. Predictors of subjective and objective quality of life in outpatients with schizophrenia.
    Yamauchi K, Aki H, Tomotake M, Iga J, Numata S, Motoki I, Izaki Y, Tayoshi S, Kinouchi S, Sumitani S, Tayoshi S, Takikawa Y, Kaneda Y, Taniguchi T, Ishimoto Y, Ueno S, Ohmori T.
    Psychiatry Clin Neurosci; 2008 Aug 13; 62(4):404-11. PubMed ID: 18778437
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.
    Naber D.
    Int Clin Psychopharmacol; 1995 Sep 13; 10 Suppl 3():133-8. PubMed ID: 8866775
    [Abstract] [Full Text] [Related]

  • 15. Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.
    Vothknecht S, Schoevers RA, de Haan L.
    Aust N Z J Psychiatry; 2011 Mar 13; 45(3):182-92. PubMed ID: 21438745
    [Abstract] [Full Text] [Related]

  • 16. An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study.
    Chou YH, Chiu NM, Yang TT, Feng J, Chan CC, Lee HK, OSCAR-S Study Group.
    Int Clin Psychopharmacol; 2013 Sep 13; 28(5):255-60. PubMed ID: 23820333
    [Abstract] [Full Text] [Related]

  • 17. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V, Seemüller F, Obermeier M, Adli M, Bauer M, Mundt C, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Mayr A, Möller HJ, Riedel M.
    J Affect Disord; 2009 Jun 13; 115(3):439-49. PubMed ID: 19027961
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.